Jonathan Small, C.P.A. and president of Oklahoma Council of Public Affairs (OCPA), recently wrote a “Free Market Friday” op-ed for The Journal Record to promote freedom in the delivery and payment of health care, showing how Oklahoma is better off not accepting funds to support the Affordable Care Act (ACA). Read More »

With health care spending on an upward trajectory, Alex Brill, CEO of economic policy consulting firm Matrix Global Advisors, thinks that value within the sector also must increase. Read More »

AstraZeneca announced the positive decision for CAZ AVI by CHMP. Read More »

CHMP issues positive opinion on Allergan's ENZEPI for patients with EPI Read More »

Ways and Means Committee held a hearing recently to discuss health care challenges and explore opportunities for improvement. Read More »

Low blood sugar can lead to ER visits; Prime releases research on hypoglycemic events. Read More »

CVS supports Drug Take Back Day on April 30 with events and education. Read More »

Naloxone saves lives by reversing opioid overdoses; CVS makes it available for friends and family. Read More »

The collaborations will create tools to predict how type 2 diabetics will follow their medication plans. Read More »

CMS included pharmacies as key providers in the Medicaid and CHIP Managed Care final rule. Read More »

Nonprofit partners providing Community Health Navigation will be a priority when awarding the grants. Read More »

Consumers can safely dispose of unused prescription drugs during National Prescription Drug Take Back Day. Read More »

The annual conference allows executives from retailers, suppliers and other health care providers an opportunity to network and build relationships. Read More »

Overall survival rates positive in the Phase III study of epithelial ovarian cancer treatment. Read More »

Allergan to present results of its studies at the ARVO meeting next week. Read More »

The clinical trial will test bococizumab versus a placebo in reducing the risk of a major cardiovascular event. Read More »

CSRxP announces its policy platform to address rising prescription drug prices. Read More »

Zurampic has been approved by the FDA for treatment of hyperuricemia associated with gout. Read More »

Oklahoma consumers enrolled in health plans with insurance deductibles that are yet to be reached and those who are uninsured may bear the high costs of rising drug prices, thanks to a proposed piece of legislation that would give pharmacies permission to disregard negotiated discounts with insurers and transfer the price hikes on to consumers. Read More »

CHANTIX/CHAMPIX compared to bupropion, nicotine patch and placebo; study finds significantly higher abstention rates. Read More »